Cashu
Johnson & Johnson Develops Innovative Drug Delivery System for Bladder Cancer Treatment
about 6 hours ago
Stocks
Health Care
jnj
Johnson & Johnson
NYSE: JNJ
-0.96 (-0.40%)
241.08
USD
At close at Mar 13, 20:34 UTC
Latest Johnson & Johnson News
prnewswire.com
Johnson & Johnson highlights promising first-in-human Erda-iDRS (formerly TAR-210) results in intermediate-risk non-muscle-invasive bladder cancer
3 days ago
cnbc.com
Dividend stocks are catching up to tech stocks on a key earnings metric at a critical time for the market
3 days ago
cnbc.com
The conditions are just right for this dividend-paying pharma stock as it mounts a comeback
4 days ago
benzinga.com
FDA Expands Use Of Generic Drug To Treat Autism-Linked Genetic Disorder
5 days ago
benzinga.com
Jobs Report Just Dented Most Bulletproof Sector ETF In The Market
9 days ago
prnewswire.com
Anxiety Treatment Boom: GAD Therapies Poised for Multi-Billion Dollar Expansion
11 days ago
cnbc.com
An options trade that hedges risk on this consumer stock trading at a discount
11 days ago
prnewswire.com
Johnson & Johnson therapy nipocalimab granted U.S. FDA Fast Track designation in systemic lupus erythematosus (SLE)
13 days ago
cnbc.com
Dividend Aristocrats are outperforming this year in a volatile market. These stocks are Wall Street’s favorites
13 days ago
benzinga.com
AbbVie Says 55% Of Crohn's Patients Reached Remission With Skyrizi, Bolsters Competitive Positioning Against Johnson & Johnson
14 days ago
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.